COVID-19 mRNA vaccine (Comirnaty)

URI: https://gptkb.org/entity/COVID-19_mRNA_vaccine_(Comirnaty)
GPTKB entity
Statements (50)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:age 6 months and older (varies by country)
gptkbp:approvedBy gptkb:World_Health_Organization
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
2020
gptkbp:ATCCode gptkb:J07BX03
gptkbp:boosterDoseRecommended yes
gptkbp:boosters yes
gptkbp:brand gptkb:Comirnaty
gptkbp:category gptkb:COVID-19_vaccines
mRNA vaccines
gptkbp:contains lipid nanoparticles
nucleoside-modified mRNA
gptkbp:containsAdjuvant no
gptkbp:containsPreservative no
gptkbp:countryOfOrigin gptkb:United_Kingdom
gptkbp:dateOfFirstApproval 2 December 2020
gptkbp:developedBy gptkb:Pfizer
gptkb:BioNTech
gptkbp:distribution global
gptkbp:efficacyAgainstOriginalStrain ~95%
gptkbp:emergencyServices granted in multiple countries
gptkbp:form suspension for injection
https://www.w3.org/2000/01/rdf-schema#label COVID-19 mRNA vaccine (Comirnaty)
gptkbp:indication prevention of COVID-19
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction induces immune response to SARS-CoV-2 spike protein
gptkbp:numberOfDoses 2 (primary series)
gptkbp:otherName gptkb:BNT162b2
Pfizer-BioNTech COVID-19 Vaccine
gptkbp:patent gptkb:Pfizer
gptkb:BioNTech
gptkbp:pregnancyCategory consult healthcare provider
gptkbp:routeOfAdministration intramuscular injection
gptkbp:sideEffect fever
fatigue
headache
muscle pain
anaphylaxis
chills
myocarditis
pain at injection site
gptkbp:storage -80°C to -60°C (ultra-cold)
2°C to 8°C (after thawing, for limited time)
gptkbp:target gptkb:SARS-CoV-2_spike_protein
gptkbp:updatedFormulations Omicron-adapted versions
gptkbp:WHO_EUL yes
gptkbp:bfsParent gptkb:Fosun_Pharma_(China)
gptkbp:bfsLayer 6